NCT01742000View on ClinicalTrials.gov

Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
Atherosclerosis
Interventions
DIETARY_SUPPLEMENT

Karinat

DRUG

Placebo

Sugar pill manufactured to mimic Karinat 500 mg tablet

All Listed Sponsors
lead

Institute for Atherosclerosis Research, Russia

OTHER

NCT01742000 - Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women | Biotech Hunter | Biotech Hunter